Poison control centers around the country are warning about a rise in calls of patients overdosing on Ozempic.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows.

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight.

Lentils are full of fiber, which “slows down digestion,” once again reproducing the effect of the GLP-1 drugs, at a cost of cents per meal, versus the $250 per week or more some Americans are paying when they can’t get insurance to cover the pricey shots.

The best way to maximize the weight loss benefits of Ozempic is to maintain a healthy lifestyle while taking the medication. And as we know, one key to achieving this is regular physical activity. Here,

Fox News contributor Dr. Marc Siegel explains how the rise in weight loss drugs like Ozempic could 'put a dent' in the 'junk food' industry and potentially combat alcohol abuse.